Quarterly report pursuant to Section 13 or 15(d)

Loans Payable

v3.21.2
Loans Payable
3 Months Ended
Mar. 31, 2021
Loans Payable [Abstract]  
LOANS PAYABLE

NOTE 7 - LOANS PAYABLE


Loans Payable


The below table summarizes the activity of loans payable during the three months ended March 31, 2021:


    Principal
Balance at
December 31,
2020
    Repayments     Effect of
Foreign
Exchange
Rates
    Principal
Balance at
March 31,
2021
 
Kingsbrook   $ 150,000     $ (150,000 )   $ -     $ -  
Paycheck Protection Program     53,051       -       -       53,051  
Bounce back loan scheme     68,245       -       582       68,827  
Other loans payable     810,913       (218,532 )     -       592,381  
Total loans payable     1,082,209       (368,532 )     582       714,259  
Less: loans payable - current portion     968,446       (362,151 )    

-

      606,295  
Loans payable - non-current portion   $ 113,763     $ (6,381 )   $ 582     $ 107,964  

On March 3, 2021, the Company repaid the Kingsbrook loans payable in cash for an aggregate of $166,313, which included the principal of $150,000 and accrued interest of $16,313.


During the three months ended March 31, 2021, the Company paid an aggregate of $218,532 in partial satisfaction of other loans payable.


Loans Payable- Related Parties


The below table summarizes the activity of loans payable - related parties during the three months ended March 31, 2021:


    Principal
Balance at
December 31,
2020
    Effect of
Foreign
Exchange
Rates
    Principal
Balance at
March 31,
2021
 
Loans payable issued between                        
September 18, 2019 through November 4, 2020   $ 513,082     $ 1,058     $ 514,140  

On February 10, 2021, the Company entered into amended loan agreements to modify the terms of certain loan agreements in the aggregate principal amount of $432,699, previously entered into with Sir Marc Feldmann and Dr. Lawrence Steinman, the Co-Executive Chairmen of the Board of Directors. The loan agreements were extended and modified to be paid back at the Company’s discretion, either by 1) repayment in cash, or 2) by converting the outstanding amounts into shares of common stock at the same price per share as the next financing transaction. Subsequently, on February 25, 2021, and effective as of the date of the original February 10, 2021 amendments, the Company determined that such amendments were entered into in error and each of Sir Feldmann and Dr. Steinman rescinded such February 10, 2021 amendments. See Note 12 – Subsequent Events.


Interest Expense on Loans Payable


For the three months ended March 31, 2021, the Company recognized interest expense and interest expense — related parties associated with the loans of $8,257 and $10,103, respectively. During the three months ended March 31, 2020, the Company recognized interest expense and interest expense — related parties associated with the loans of $14,885 and $6,638, respectively.


As of March 31, 2021, the Company had accrued interest and accrued interest — related parties associated with the loans of $16,946 and $47,694, respectively. As of December 31, 2020, the Company had accrued interest and accrued interest — related parties associated with the loans of $24,824 and $37,539, respectively. See Note 11 — Related Parties for additional details.